The closing price of Biohaven Ltd. (NYSE: BHVN) was $18.28 for the day, down -4.29% from the previous closing price of $19.10. In other words, the price has decreased by -$0.82 from its previous closing price. On the day, 535099 shares were traded. BHVN stock price reached its highest trading level at $18.95 during the session, while it also had its lowest trading level at $17.82.
Our analysis of BHVN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, SVB Securities on January 24, 2023, initiated with a Outperform rating and assigned the stock a target price of $24.
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 30 when CHILDS JOHN W bought 50,000 shares for $18.44 per share. The transaction valued at 922,180 led to the insider holds 1,975,118 shares of the business.
CHILDS JOHN W bought 100,000 shares of BHVN for $1,978,430 on Aug 04. The Director now owns 1,925,118 shares after completing the transaction at $19.78 per share. On Oct 31, another insider, Coric Vlad, who serves as the Chief Executive Officer of the company, bought 25,800 shares for $15.97 each. As a result, the insider paid 411,995 and bolstered with 1,543,394 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 1.25B and an Enterprise Value of 942.84M.
Stock Price History:
Over the past 52 weeks, BHVN has reached a high of $26.64, while it has fallen to a 52-week low of $5.54. The 50-Day Moving Average of the stock is 20.75, while the 200-Day Moving Average is calculated to be 17.56.
BHVN traded an average of 969.20K shares per day over the past three months and 972.04k shares per day over the past ten days. A total of 68.25M shares are outstanding, with a floating share count of 55.19M. Insiders hold about 13.20% of the company’s shares, while institutions hold 14.70% stake in the company. Shares short for BHVN as of Aug 30, 2023 were 5.25M with a Short Ratio of 5.25M, compared to 4.9M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 7.68% and a Short% of Float of 8.99%.
The firm’s stock currently is rated by 7 analysts. On average, analysts expect EPS of -$1.34 for the current quarter, with a high estimate of -$1.26 and a low estimate of -$1.4, while EPS last year was -$1.75. The consensus estimate for the next quarter is -$1.35, with high estimates of -$1.25 and low estimates of -$1.44.
Analysts are recommending an EPS of between -$4.55 and -$5.2 for the fiscal current year, implying an average EPS of -$5.01. EPS for the following year is -$4.86, with 7 analysts recommending between -$2.84 and -$6.14.